P-223 An eleven-lncRNA signature predicts overall survival in patients with gastric cancer

Abstract

Gastric cancer (GC) is one of the most common malignancies worldwide. Multidisciplinary strategies including chemotherapy, radiotherapy and surgical resection are the basic treatment for stomach cancer and significantly improve the survival of patients with GC. However, the prognosis of patients with advanced GC remains poor. The high risk of disease relapse prompted the investigation of genomic factors which could be the predictive or prognostic biomarkers of GC. Thus, we established a multi-gene prognostic model for predicting the prognosis of GC and explored crucial molecular mechanisms associated with prognostic lncRNA expression signature.